Journal of Internal Medicine Concepts & Practice >

2024 , Vol. 19 >Issue 04: 254 - 258

DOI: https://doi.org/10.16138/j.1673-6087.2024.04.07

Case report

Ultrasound features and clinical manifestations of two cases of thyroid metastatic cancer: pay attention to abnormal thyroid ultrasound spectrum

  • LI Yuanyuan ,
  • DING Wenbo ,
  • JIANG Ziyu ,
  • CHEN Xi ,
  • LIU Binbin ,
  • CHEN Guofang ,
  • LIU Chao
Expand
  • a. Endocrine and Diabetes Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
    b. Department of Ultrasound, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
    c. Department of Oncology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China
    d. Department of Pathology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China

Received date: 2023-12-27

  Online published: 2024-11-11

Fold

Abstract

Ultrasonography plays an important role in early screening of thyroid cancer. This article introduced two cases of thyroid metastatic carcinoma secondary to renal clear cell carcinoma and cervical squamous cell carcinoma respectively, analyzed their clinical diagnosis and treatment process, ultrasound characteristics, and prognosis, as well as reviewed the related literature. As atypical thyroid lesions were detected through the ultrasound spectrum in patients with a history of malignant tumors, it should be alert to the possibility of metastatic cancer. Ultrasound-guided core-needle biopsy combined with immunohistochemical testing can help early diagnosis and timely treatment.

Key words： Thyroid metastatic carcinoma; Ultrasound features; Renal clear cell carcinoma; Cervical squamous cell carcinoma; Core needle biopsy

Cite this article

LI Yuanyuan , DING Wenbo , JIANG Ziyu , CHEN Xi , LIU Binbin , CHEN Guofang , LIU Chao . Ultrasound features and clinical manifestations of two cases of thyroid metastatic cancer: pay attention to abnormal thyroid ultrasound spectrum[J]. Journal of Internal Medicine Concepts & Practice, 2024 , 19(04) : 254 -258 . DOI: 10.16138/j.1673-6087.2024.04.07

References

[1] Pizzato M, Li M, Vignat J, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020[J]. Lancet Diabetes Endocrinol, 2022, 10(4):264-272.
[2] Chung AY, Tran TB, Brumund KT, et al. Metastases to the thyroid: a review of the literature from the last decade[J]. Thyroid, 2012, 22(3):258-268.
[3] Cheung AY, Donner L, Capen C. Metastatic adenocarcinoma of the uterine cervix to the thyroid gland[J]. Clin Oncol (R Coll Radiol), 2000, 12(1):60-61.
[4] Moghaddam PA, Cornejo KM, Khan A. Metastatic carcinoma to the thyroid gland: a single institution 20-year experience and review of the literature[J]. Endocr Pathol, 2013, 24(3):116-124.
[5] Cipriani NA, Agarwal S, Dias-Santagata D, et al. Clear cell change in thyroid carcinoma: a clinicopathologic and molecular study with identification of variable genetic anomalies[J]. Thyroid, 2017, 27(6):819-824.
[6] Spain L, Diem S, Larkin J. Management of toxicities of immune checkpoint inhibitors[J]. Cancer Treat Rev, 2016,44:51-60.
[7] Ghossein CA, Khimraj A, Dogan S, et al. Metastasis to the thyroid gland: a single-institution 16-year experience[J]. Histopathology, 2021, 78(4):508-519.
[8] Saito Y, Sugitani I, Toda K, et al. Metastatic thyroid tumors: ultrasonographic features, prognostic factors and outcomes in 29 cases[J]. Surg Today, 2014, 44(1):55-61.
[9] Yildirim Simsir I, Cetinkalp S, Kabalak T. Review of factors contributing to nodular goiter and thyroid carcinoma[J]. Med Princ Pract, 2020, 29(1):1-5.
[10] Heffess CS, Wenig BM, Thompson LD. Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases[J]. Cancer, 2002, 95(9):1869-1878.
Options
Outlines

/

〈 〉